Dabomb Protein Biotech Corporation(TW:6578)
NT$17.00+0.10 (+0.59%)
TW:6578
Dabomb Protein Biotech Corporation Revenue
NT$17.00
At close:+0.10 (+0.59%)
Dabomb Protein Biotech Corporation (6578) Revenue
Dabomb Protein Biotech Corporation Revenue
Dabomb Protein Biotech Corporation had a revenue of 107.48M in the quarter ending Jun 30, 2026, with 30.93%. This bring the company's revenue in the last twelve months to 339.44M, Increased 5.15%. In the fiscal year ending Dec 31, 2025, Dabomb Protein Biotech Corporation had annual revenue of 309.33M with -8.43% growth.
- Revenue (ttm)
- 339.44M
- Revenue Growth
- 21.50%
- P/S Ratio
- 3.90
- Revenue/Employee
- TWD 6,724,674
- Employees
- 46
- Market Cap
- TWD 1.21B
Revenue Chart
Dabomb Protein Biotech Corporation Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 309.33M | -28.49M | -8.43% |
| Dec 31, 2024 | 337.82M | -46.59M | -12.12% |
| Dec 31, 2023 | 384.41M | -49.22M | -11.35% |
| Dec 31, 2022 | 433.63M | -37.00M | -7.86% |
| Dec 31, 2021 | 470.63M | -134.59M | -22.24% |
| Dec 31, 2020 | 605.22M | -41.38M | -6.40% |
| Dec 31, 2019 | 646.60M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.